NID1 and non-small cell lung carcinoma: In addition, to validate these results, we also performed a parallel analysis based on ACSL3, NID1, and RETN expression in larger series of NSCLC samples from The Cancer Genome Atlas (TCGA) study, ACSL and RETN expression had an overall survival risk effect [16].